SunBio, Inc. develops biosimilars, biopharmaceuticals, medical devices, and cosmetic products based on proprietary technologies comprised of site-directed pegylation of proteins, cell engineering technology, and novel pegylation technologies. The company was founded on June 10, 1997 and is headquartered in Gunpo-si, South Korea.